Quantification of vancomycin in human serum by LC-MS/MS

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 9, 2013, Pages 1761-1769

  König, Katrin ^a   Kobold, Uwe ^b   Fink, Gerhard ^b   Leinenbach, Andreas ^b   Dülffer, Thomas ^b   Thiele, Roland ^b   Zander, Johannes ^a   Vogeser, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

LC MS MS; Liquid chromatography; Mass spectrometry; Serum; Vancomycin

Indexed keywords

UNCLASSIFIED DRUG; VANCOMYCIN; VANCOMYCIN DERIVATIVE; VANCOMYCIN GLYCINE METHYL ESTER;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG RETENTION; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IONIZATION; MEASUREMENT ACCURACY; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; STANDARDIZATION; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRAFILTRATION; VALIDATION STUDY;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; VANCOMYCIN;

EID: 84888111328     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0142     Document Type: Article

References (13)

1. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr., Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm 2009;66: 82-98.
2. Roberts JA, Norris R, Paterson DL, Martin JH. Therapeutic drug monitoring of antimicrobials. Br J Clin Pharmacol 2012;73: 27-36.
3. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 2004;43: 925-42. (Pubitemid 39447034)
4. Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther 2012;34: 149-57.
5. Wong-Beringer A, Joo J, Tse E, Beringer P. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Int J Antimicrob Agents 2011;37: 95-101.
6. Wilson JF, Davis AC, Tobin CM. Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment. J Antimicrob Chemother 2003;52: 78-82. (Pubitemid 36850089)
7. Cass RT, Villa JS, Karr DE, Schmidt DE Jr. Rapid bioanalysis of vancomycin in serum and urine by high-performance liquid chromatography tandem mass spectrometry using on-line sample extraction and parallel analytical columns. Rapid Commun Mass Spectrom 2001;15: 406-12. (Pubitemid 32273862)
8. Zhang T, Watson DG, Azike C, Tettey JN, Stearns AT, Binning AR, et al. Determination of vancomycin in serum by liquid chromatography-high resolution full scan mass spectrometry. J Chromatogr B 2007;857: 352-6. (Pubitemid 47444592)
9. Shibata N, Ishida M, Prasad YV, Gao W, Yoshikawa Y, Takada K. Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailability in rats. J Chromatogr B 2003;789: 211-8. (Pubitemid 36549190)
10. Stepman HC, Vanderroost A, Van Uytfanghe K, Thienpont LM. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2011;57: 441-8.
11. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49: 1041-4. (Pubitemid 36751088)
12. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;75: 3019-30. (Pubitemid 36830428)
13. Guidance for Industry-Bioanalytical Method Validation. U.S. Department of Health and Human Services-Food and Drug Administration; 2001. Available from: http://www.fda.gov/ downloads/Drugs/*/Guidances/ucm070107.pdf. Accessed on February, 2012.